| Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 14, as of September 30, 2025 and December 31, 2024 by fair value hierarchy level were as follows: September 30, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 331,918 | | | $ | — | | | $ | — | | | $ | 331,918 | | | Investment securities - fair value | | | | | | | | | Sponsored funds | 56,383 | | | — | | | — | | | 56,383 | | | Equity securities | 22,124 | | | — | | | — | | | 22,124 | | | Debt securities | — | | | 2,403 | | | 29,651 | | | 32,054 | | | | | | | | | | | Nonqualified retirement plan assets | 19,606 | | | — | | | — | | | 19,606 | | | Total assets measured at fair value | $ | 430,031 | | | $ | 2,403 | | | $ | 29,651 | | | $ | 462,085 | | | | | | | | | | | Liabilities | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 20,000 | | | $ | 20,000 | | | Total liabilities measured at fair value | $ | — | | | $ | — | | | $ | 20,000 | | | $ | 20,000 | |
December 31, 2024 | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 225,736 | | | $ | — | | | $ | — | | | $ | 225,736 | | | Investment securities - fair value | | | | | | | | | Sponsored funds | 63,296 | | | — | | | — | | | 63,296 | | | Equity securities | 19,019 | | | — | | | — | | | 19,019 | | | Debt securities | — | | | 1,456 | | | — | | | 1,456 | | | | | | | | | | | Nonqualified retirement plan assets | 15,159 | | | — | | | — | | | 15,159 | | | Total assets measured at fair value | $ | 323,210 | | | $ | 1,456 | | | $ | — | | | $ | 324,666 | | | | | | | | | | | Liabilities | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 36,100 | | | $ | 36,100 | | | Total liabilities measured at fair value | $ | — | | | $ | — | | | $ | 36,100 | | | $ | 36,100 | |
The assets and liabilities of CIP measured at fair value on a recurring basis as of September 30, 2025 and December 31, 2024 by fair value hierarchy level were as follows: | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2025 | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 85,952 | | | $ | — | | | $ | — | | | $ | 85,952 | | | Debt investments | 53 | | | 2,163,678 | | | 28,649 | | | 2,192,380 | | | Equity investments | 45,736 | | | 25 | | | 577 | | | 46,338 | | | | | | | | | | | Total assets measured at fair value | $ | 131,741 | | | $ | 2,163,703 | | | $ | 29,226 | | | $ | 2,324,670 | | | Liabilities | | | | | | | | | Notes payable | $ | — | | | $ | 2,030,580 | | | $ | — | | | $ | 2,030,580 | | | Short sales | 272 | | | — | | | — | | | 272 | | | | | | | | | | | Total liabilities measured at fair value | $ | 272 | | | $ | 2,030,580 | | | $ | — | | | $ | 2,030,852 | |
| | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 127,695 | | | $ | — | | | $ | — | | | $ | 127,695 | | | Debt investments | — | | | 2,239,924 | | | 6,676 | | | 2,246,600 | | | Equity investments | 22,993 | | | 111 | | | 1,013 | | | 24,117 | | | | | | | | | | | Total assets measured at fair value | $ | 150,688 | | | $ | 2,240,035 | | | $ | 7,689 | | | $ | 2,398,412 | | | Liabilities | | | | | | | | | Notes payable | $ | — | | | $ | 2,171,946 | | | $ | — | | | $ | 2,171,946 | | | | | | | | | | | Short sales | 356 | | | — | | | — | | | 356 | | | Total liabilities measured at fair value | $ | 356 | | | $ | 2,171,946 | | | $ | — | | | $ | 2,172,302 | |
|
| Schedule of Reconciliation of Assets of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value |
The following table presents a reconciliation of beginning and ending balances of the Company's Level 3 debt securities:
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | Debt securities, beginning of period | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | Purchases (sales), net | 29,651 | | | 24,443 | | | 29,651 | | | 24,443 | | | | | | | | | | | | | | | | | | | Debt securities, end of period | $ | 29,651 | | | $ | 24,443 | | | $ | 29,651 | | | $ | 24,443 | | | | | | | | | |
The following table is a reconciliation of assets of CIP for Level 3 investments for which significant unobservable inputs were used to determine fair value: | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | | (in thousands) | 2025 | | 2024 | | | | Balance at beginning of period | $ | 7,689 | | | $ | 37,062 | | | | | | | | | | | | | | | | | Realized and unrealized gains (losses), net | (1,872) | | | 918 | | | | | | | | | | | Purchases | 2,398 | | | 19 | | | | | | | | | | | | | | | | | Sales | (49,282) | | | (36,452) | | | | | Transfers to Level 2 | (50,208) | | | (71,236) | | | | | Transfers from Level 2 | 120,501 | | | 125,527 | | | | | Balance at end of period (1) | $ | 29,226 | | | $ | 55,838 | | | |
(1)The investments that are categorized as Level 3 were valued utilizing third-party pricing information without adjustment. Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable at period end.
|
| Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value |
The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Contingent consideration, beginning of period | $ | 20,000 | | | $ | 38,408 | | | $ | 36,100 | | | $ | 56,200 | | | | | | | | | | | | | | | | | | | Reduction for payments made | — | | | — | | | (13,086) | | | (14,492) | | | Increase (reduction) of liability related to re-measurement of fair value | — | | | (4,000) | | | (3,014) | | | (7,300) | | | Contingent consideration, end of period | $ | 20,000 | | | $ | 34,408 | | | $ | 20,000 | | | $ | 34,408 | |
|